(Q54569428)

1 June 2018

title

5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. (English)

1 reference

1 June 2018

1 reference

7

1 reference

1 June 2018

Peter Boyle

10

1 reference

1 June 2018

Graham Giles

11

1 reference

1 June 2018

Wayne D Tilley

Wayne D Tilley

5

0 references

Gianluca Severi

Gianluca Severi

2

0 references

Melissa C. Southey

Melissa C Southey

6

0 references

John Hopper

9

John L Hopper

1 reference

1 June 2018

1

Vanessa M Hayes

1 reference

1 June 2018

Emma Padilla

3

Emma J D Padilla

1 reference

1 June 2018

author name string

Howard A Morris

4

1 reference

1 June 2018

Robert L Sutherland

8

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 February 2007

1 reference

1 June 2018

International Journal of Cancer

published in

1 reference

1 June 2018

volume

120

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

776-780

1 reference

1 June 2018

PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor

cites work

1 reference

Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism

21 January 2018

1 reference

Prospective study of sex hormone levels and risk of prostate cancer

21 January 2018

1 reference

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

21 January 2018

1 reference

Circulating steroid hormones and the risk of prostate cancer

21 January 2018

1 reference

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

21 January 2018

1 reference

Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1

21 January 2018

1 reference

Genetic analysis of male pattern baldness and the 5alpha-reductase genes

21 January 2018

1 reference

Smoking and prostate cancer: Findings from an Australian case-control study

21 January 2018

1 reference

The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia

21 January 2018

1 reference

A comparison of linkage disequilibrium measures for fine-scale mapping

21 January 2018

1 reference

Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.

21 January 2018

1 reference

Association between hormonal genetic polymorphisms and early-onset prostate cancer

21 January 2018

1 reference

The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population

21 January 2018

1 reference

5alpha-reductase 2 polymorphisms as risk factors in prostate cancer

21 January 2018

1 reference

Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.

21 January 2018

1 reference

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

21 January 2018

1 reference

The genetics of androgenetic alopecia.

21 January 2018

1 reference

Polymorphism of the androgen receptor gene is associated with male pattern baldness.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.22408

1 reference

1 June 2018

1 reference

1 June 2018